CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer PrognosisAmanda Sosulski(Harvard University), David Pépin(Harvard University)PLoS ONEJune 2, 201610.1371/journal.pone.0156595Cited by 47SaveCiteExport RISWatch citationsRelated PapersGenetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination Immunotherapy|Cancer Discovery|2020|138